These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16686903)

  • 41. Tactile-induced ultrasonic vocalization in the rat: a novel assay to assess anti-migraine therapies in vivo.
    Martino G; Perkins MN
    Cephalalgia; 2008 Jul; 28(7):723-33. PubMed ID: 18498397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurobiology of migraine.
    Goadsby PJ; Charbit AR; Andreou AP; Akerman S; Holland PR
    Neuroscience; 2009 Jun; 161(2):327-41. PubMed ID: 19303917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of attack frequency in migraine treatment.
    Maas HJ; Snelder N; Danhof M; Della Pasqua O
    Cephalalgia; 2008 Aug; 28(8):847-55. PubMed ID: 18540870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostaglandins in migraine: update.
    Antonova M; Wienecke T; Olesen J; Ashina M
    Curr Opin Neurol; 2013 Jun; 26(3):269-75. PubMed ID: 23519238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology of migraine.
    Cutrer FM
    Semin Neurol; 2006 Apr; 26(2):171-80. PubMed ID: 16628527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment.
    Moskowitz MA
    Funct Neurol; 2007; 22(3):133-6. PubMed ID: 17925161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sumatriptan and corneal reflexes in headache-free migraine patients: a randomized and placebo-controlled crossover study.
    Busch V; Kaube S; Schulte-Mattler W; Kaube H; May A
    Cephalalgia; 2007 Feb; 27(2):165-72. PubMed ID: 17257238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Migraine and nerve block].
    Higa S
    Nihon Rinsho; 2001 Sep; 59(9):1717-21. PubMed ID: 11554041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Migraine--mechanisms and consequences for treatment].
    Alstadhaug KB; Salvesen R
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3064-8. PubMed ID: 18049496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current viewpoints on etiology and physiopathology of migraine].
    Salvesen R
    Tidsskr Nor Laegeforen; 1999 Apr; 119(10):1437-43. PubMed ID: 10354752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral and central activation of trigeminal pain pathways in migraine: data from experimental animal models.
    Buzzi MG; Tassorelli C; Nappi G
    Cephalalgia; 2003; 23 Suppl 1():1-4. PubMed ID: 12699454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapy and prevention of migraine. New recommendations and their practical application].
    Einecke D
    MMW Fortschr Med; 2001 Feb; 143(8):4-7. PubMed ID: 11265538
    [No Abstract]   [Full Text] [Related]  

  • 53. Migraine--disease or syndrome?
    Edmeads J
    Pathol Biol (Paris); 1992 Apr; 40(4):279-83. PubMed ID: 1495811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sensitization of the trigeminal sensory system during different stages of the rat estrous cycle: implications for menstrual migraine.
    Martin VT; Lee J; Behbehani MM
    Headache; 2007 Apr; 47(4):552-63. PubMed ID: 17445105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [28. Acute therapy and prevention of migraine].
    Diener HC
    MMW Fortschr Med; 2002 Jan; 144(3-4):I-X; quiz XI-II. PubMed ID: 11862804
    [No Abstract]   [Full Text] [Related]  

  • 56. High spatiotemporal resolution imaging of the neurovascular response to electrical stimulation of rat peripheral trigeminal nerve as revealed by in vivo temporal laser speckle contrast.
    Li N; Jia X; Murari K; Parlapalli R; Rege A; Thakor NV
    J Neurosci Methods; 2009 Jan; 176(2):230-6. PubMed ID: 18706442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cortico-NRM influences on trigeminal neuronal sensation.
    Lambert GA; Hoskin KL; Zagami AS
    Cephalalgia; 2008 Jun; 28(6):640-52. PubMed ID: 18454788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The neurogenic basis of migraine.
    Cutrer FM; Charles A
    Headache; 2008 Oct; 48(9):1411-4. PubMed ID: 19006559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.